Format

Send to

Choose Destination
Int J Pediatr Otorhinolaryngol. 2016 May;84:52-4. doi: 10.1016/j.ijporl.2016.02.005. Epub 2016 Feb 12.

Use of intravenous propranolol for control of a large cervicofacial hemangioma in a critically ill neonate.

Author information

1
Department of Otolaryngology - Head and Neck Surgery, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, PV01, Portland, OR 97239, USA; School of Medicine, Vanderbilt University, 201 Light Hall, 2215 Garland Avenue, Nashville, TN 37232, USA. Electronic address: Shanik.fernando@vanderbilt.edu.
2
Department of Dermatology, Oregon Health & Science University, Center for Health & Healing, Mail code: CH16D, 3303 SW Bond Avenue, Portland, OR 97239, USA.
3
Department of Otolaryngology - Head and Neck Surgery, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, PV01, Portland, OR 97239, USA.

Abstract

Cervicofacial segmental infantile hemangiomas (IH) may result in airway obstruction requiring use of propranolol to induce hemangioma regression and reestablish the airway. We present the first case using intravenous (IV) propranolol for control of airway obstruction and rapid expansion of cervicofacial IH in the setting of necrotizing enterocolitis (NEC) impaired gastrointestinal function. Intravenous dosing of propranolol was tolerated well in a critically ill neonate with multisystem complications of prematurity.

KEYWORDS:

Airway; Necrotizing enterocolitis; Propranolol; Segmental infantile hemangioma; Vascular anomaly

PMID:
27063753
DOI:
10.1016/j.ijporl.2016.02.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center